Singleron Biotechnologies is an innovative and rapidly growing company providing complete solutions for single cell sequencing technologies. To improve clinical diagnosis, drug development, and health management, Singleron brings breakthrough single cell analysis techniques to clinicians and researchers.
Dr. Fang has over a decade of expertise in product development, commercialization, team management, and corporate strategy. She draws her expertise from previous roles as Deputy GM at Novogene and leading to the successful launch of 30+ products at QIAGEN. Recognitions: Forbes CN top 50 women.
As a seasoned biotech entrepreneur and former Proteona CEO, Dr. Schmidt brings a wealth of experience, having led AYOXXA Biosystems for 7 years. He served on boards of multiple biotech firms and provided advisory support to research institutes incl. EIT, Duke-NUS Medical School, SMART, and Scaler8.
With 20+ years in R&D Dr. Scolnick’s expertise spans academia and clinical services companies like Natera and Nugen Technologies. As the former Co-founder and CSO at Proteona, he led the development of wet and dry lab tools for single-cell tech. to predict patient responses to drugs.
Dr. Zhou has a decade of expertise in mechanical engineering, electronic technology, materials science, biotechnology, and stem cells. Before co-founding Singleron, she served as a Patent Agent at Dilworth IP LLC. She advised the CEO of IsoPlexis Inc. and was Associate Research Scientist at Yale.
Gao was senior manager in the audit and assurance section of Deloitte Touche Tohmatsu. Mr. Gao held various roles at Baixing Co., Ltd., including CFO and director. He also served as CFO of Frontage Holdings Group, successfully leading its IPO in 2019.
Dr. Buettner, a leading pathologist, has pioneered NGS and breakthrough technologies in clinical applications. He serves on the boards of LNS, Luxembourg, and the German Cancer Aid, and is the Founding President of the Vladimir Totovic Foundation/German Pathology.
Dr. Sun, an esteemed expert in Reproductive Biology and Medicine. Recognized for outstanding research, he received numerous awards, including the Canadian Fertility and Andrology Society Best Basic Science Research Paper (2004), and Chief scientist of National 973 program.
Dr. Koretzky is a globally recognized immunologist and significantly contributed to the understanding of immune system cell development. He holds fellowships with the American Academy of Arts and Sciences, American Association for the Advancement of Science.
Dr. Loeffert is a senior executive of the Life Sciences industry with more than 20 years of experience in product development and commercialization. Previously, he was Vice President of Product Development at QIAGEN, in charge of all product development activities of the Life Sciences Business Area.
Dr. Fan is an expert in cutting-edge single-cell micro/nano-technologies, investigating cellular heterogeneity and inter-cellular signaling networks in health and disease. He co-founded IsoPlexis, creator of IsoCode technology, ranked #1 in 2017 Top 10 Innovations.
We are always looking for motivated and dedicated candidates. Check out our current open positions and reach out to us.